Handbook of Clinical Psychopharmacology for Therapists
440Handbook of Clinical Psychopharmacology for Therapists
440eBookTenth Edition (Tenth Edition)
Available on Compatible NOOK devices, the free NOOK App and in My Digital Library.
Related collections and offers
Overview
A comprehensive resource for mental health professionals—now in a fully revised and updated tenth edition.
The Handbook of Clinical Psychopharmacology for Therapists is the gold standard for mental health clinicians looking for clear, reliable information about the pharmacological treatment of mental health conditions. Organized by disorder and, within each disorder, by medication, this book is designed to familiarize clinicians and students with the basic terminology and models of psychopharmacology.
This fully revised and updated tenth edition provides essential information on medications and treatment options, and includes the latest research on side effects, contraindications, and efficacy of all major medications prescribed for mental health disorders.
This handbook makes it simple to:
- Get the facts about drug interactions and side effects
- Find out how medications affect adults, children, and adolescents differently
- Learn how different cultures view medical treatment—vital information for anyone treating clients from a variety of backgrounds
- Discontinue medication safely when needed
The book also includes new material on novel and emerging medications, ethnopsychopharmacology, genomic testing, and psychopharmacology with older adults.
This comprehensive guide to psychopharmacology has been adopted as a textbook at universities nationwide and is an important resource for every therapist’s library.
Product Details
ISBN-13: | 9781648483707 |
---|---|
Publisher: | New Harbinger Publications |
Publication date: | 01/02/2025 |
Sold by: | Barnes & Noble |
Format: | eBook |
Pages: | 440 |
About the Author
John D. Preston, PsyD, ABPP, (1950-2020), was a licensed psychologist, and author or coauthor of twenty books. He was professor emeritus of psychology at Alliant International University, and served on the faculty of the UC Davis School of Medicine. Preston lectured widely in the United States and abroad. He was a recipient of the Mental Health Association’s President’s Award for contributions to the mental health professions, and was a fellow of the American Psychological Association.
Bret A. Moore, PsyD, ABPP, is a prescribing psychologist and board-certified clinical psychologist in San Antonio, Texas. Moore’s primary specialties include clinical psychopharmacology and military psychology. In addition to maintaining an active practice in clinical psychopharmacology over the past 15 years, Moore has designed and taught courses in psychopharmacology, clinical medicine, and military psychology for the University of Missouri, Fairleigh Dickinson University, and Chicago School of Professional Psychology. Moore has authored and edited 24 books, dozens of book chapters, and over 50 peer-reviewed and professional articles.
John H. O’Neal, MD, is a board-certified psychiatrist who has been in private practice since 1977. He is past chief of the department of psychiatry at Sutter Community Hospital in Sacramento, CA and was an associate clinical professor of psychiatry at the UC Davis School of Medicine. He is a Distinguished Fellow of the American Psychiatric Association. He lectures on depression and psychopharmacology to mental health professionals, employee assistance programs, and the public. Dr. O’Neal received his master’s in clinical psychology from Harvard University, and Doctor of Medicine from the University of Washington.
Mary C. Talaga, RPh, PhD, has been a pharmacist since 1977, with specialization in psychiatric pharmacy and pharmacy administration. She has extensive experience in health care, and has practiced in a variety of clinical settings. Over her career, she has contributed to the development of best practice guidelines, and has promoted collaborative care models. She has provided training and mentoring to health care professionals, and education to patients and consumers.
Bret A. Moore, PsyD, ABPP, is a board-certified clinical and prescribing psychologist in San Antonio, TX. Over the past twelve years, he has taught graduate-level courses in clinical psychopharmacology for multiple universities and colleges. He is the recipient of the Educator of the Year award from the American Society for the Advancement of Pharmacotherapy, and is a fellow of the American Psychological Association.
John H. O’Neal, MD, is a board-certified psychiatrist who has been in private practice since 1977. He is past chief of the department of psychiatry at Sutter Community Hospital in Sacramento, CA. He is associate clinical professor of psychiatry at the UC Davis School of Medicine, and a fellow of the American Psychiatric Association. He lectures on depression and psychopharmacology to mental health professionals, employee assistance programs, and the public. O’Neal received his master’s in clinical psychology from Harvard University, and doctor of medicine from the University of Washington.
Mary C. Talaga, RPh, PhD, has been a pharmacist for thirty-nine years, with specialization in psychiatric pharmacy and pharmacy administration. She has extensive experience in health care, and has practiced in a variety of clinical settings. Over her career, she has contributed to the development of best practice guidelines, and has promoted collaborative care models. She has provided training and mentoring to health care professionals, and education to patients and consumers.
Table of Contents
Acknowledgments ix
Part 1 Understanding Psychopharmacology: The Basics
1 Introduction 3
2 Integrated Models 15
3 Neurobiology 29
4 Pharmacology 45
5 Medication Nonadherence 57
Part 2 Clinical Syndromes: Etiology, Diagnosis, and Treatment Implications
6 Preliminary Diagnostic Considerations 65
7 Depressive Disorders 77
8 Bipolar Disorders 95
9 Anxiety Disorders 107
10 Obsessive-Compulsive Disorder 123
11 Psychotic Disorders 129
12 Post-Traumatic Stress Disorder 139
13 Borderline Personality Disorders 147
14 Substance-Related Disorders 153
15 Other Miscellaneous Disorders 161
Part 3 Medications
16 Antidepressant Medications 175
17 Bipolar Medications 201
18 Antianxiety Medications 217
19 Antipsychotic Medications 227
20 Over-the-Counter Dietary Supplements and Herbal Products 239
21 Medication Discontinuation 243
22 Red Flags: When to Reevaluate 247
23 Child and Adolescent Psychopharmacology 255
Epilogue: On the Horizon 277
Appendix A Pharmacokinetics 279
Appendix B Pharmacotherapy in Special Populations 285
Appendix C Psychotropic Drug Interactions 293
Appendix D Differentiating Psychotropic Side Effects from Psychiatric Symptoms 309
Appendix E Neurocognitive Mental Status Exam 313
Appendix F Trade Versus Generic Drug Names: A Quick Reference 317
Appendix G Medication Safety 321
Appendix H Books for Patients About Medication Treatment 325
Appendix I Patient Information Sheets on Psychiatric Medications 327
References 343
Index 363
Interviews
Preston lives in Shingle Springs, CA; Moore lives in San Antonio, TX; O’Neal lives in the Greater San Francisco Bay Area; Talaga lives in Fair Oaks, CA.